14-046
Showing 1 - 25 of 7,140
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (BEA 2180 BR, Tiotropium Bromide, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- BEA 2180 BR
- +2 more
-
Jasper, Alabama
- +177 more
Jul 30, 2021
HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)
Not yet recruiting
- HER2-positive Locally Advanced Resectable Gastric Cancer
- KN026
- +2 more
- (no location specified)
Sep 3, 2023
Hunter Syndrome Trial in Canada, France (Idursulfase-IT, Elaprase)
Not yet recruiting
- Hunter Syndrome
-
Calgary, Alberta, Canada
- +3 more
Sep 4, 2023
Advanced NSCLC Trial in China (KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein
Enrolling by invitation
- Advanced Non-small Cell Lung Cancer
- KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection)
- Axitinib
-
Hefei, Anhui, China
- +5 more
Oct 26, 2022
Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)
Recruiting
- Mycobacterium Infections, Nontuberculous
- ALIS
- +3 more
-
Birmingham, Alabama
- +172 more
Jan 23, 2023
Solid Tumor Trial in Tainan (GT90001+KN046, GT90001/KN046)
Recruiting
- Solid Tumor
-
Tainan, TaiwanChi-Mei Medical Center
Nov 25, 2021
HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)
Not yet recruiting
- HER2-positive Colorectal Cancer
- HER2-positive Biliary Tract Cancer
- KN026
- +2 more
-
Beijing, State*, ChinaPeking University cancer hospital & institution
Aug 2, 2023
Mullerian Duct Anomalies Trial in Assiut (prospective follow up)
Recruiting
- Mullerian Duct Anomalies
- prospective follow up
-
Assiut, EgyptAssiut Medical School
Oct 30, 2023
Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX plus radiotherapy
- (no location specified)
Nov 21, 2023
Sarcopenia, Osteoporosis Trial (whole-body vibration to Control)
Not yet recruiting
- Sarcopenia
- Osteoporosis
- whole-body vibration to Control
- (no location specified)
Aug 24, 2023
Exercise, Long Term Care Facilities, Physical Function Trial in Taipei (partnered multicomponent exercises program)
Completed
- Exercise
- +3 more
- partnered multicomponent exercises program
-
Taipei, TaiwanNational Taipei University of Nursing and Health Sciences
Apr 6, 2022
Human Immunodeficiency Virus-1 (HIV-1) Trial (Treatment A: Doravirine 100 mg film coated tablet, Treatment B: Doravirine 150 mg
Completed
- Human Immunodeficiency Virus-1 (HIV-1)
- Treatment A: Doravirine 100 mg film coated tablet
- +4 more
- (no location specified)
Dec 15, 2020
Switching From Cardiac Troponin I to T
Recruiting
- Acute Coronary Syndrome
- +5 more
- Clinical implementation of hs-cTnT
-
Edinburgh, United KingdomCentre for Cardiovascular Science
Feb 17, 2023
Healthy Trial in Mexico City (High-protein diet)
Not yet recruiting
- Healthy
- High-protein diet
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Jun 7, 2023
Hyperhydration and Polyneuromyopathy in Critically Ill Patients
Completed
- Respiratory Distress Syndrome, Acute
- +6 more
- Bioelectrical impedance vector analysis (BIVA)
- +2 more
-
Ostrava, Czech Republic, CzechiaUniversity Hospital Ostrava
Aug 7, 2023
IBS - Irritable Bowel Syndrome, Diarrhea Trial in Shanghai, Chengdu (QiMeiYan Probiotics, Placebo product)
Not yet recruiting
- IBS - Irritable Bowel Syndrome
- Diarrhea
- QiMeiYan Probiotics
- Placebo product
-
Shanghai, Shanghai, China
- +1 more
Jun 2, 2023
Epilepsy, Seizures Trial in Charleston (Epitel's™ Remote EEG Monitoring System's (REMI™))
Not yet recruiting
- Epilepsy
- Seizures
- Epitel's™ Remote EEG Monitoring System's (REMI™)
-
Charleston, South CarolinaMedical University of South Carolina
Aug 31, 2023